Jiangsu Hengrui Medicine repurchases shares for employee ownership plan

Jiangsu Hengrui Medicine Co., Ltd. announced on November 11, 2025, a repurchase of 150,000 A-shares, which will be held as treasury shares for its A-share employee stock ownership plan. The transaction, conducted on the Shanghai Stock Exchange, was completed at an aggregate cost of RMB 9,152,600. Shares were repurchased at prices ranging from RMB 61.01 to RMB 61.07 per share.

Following this repurchase, the company's total issued shares (excluding treasury shares) decreased by 150,000, from 6,375,873,264 to 6,375,723,264, representing a 0.0024% change in the existing issued share capital. Concurrently, the number of treasury shares increased from 3,129,010 to 3,279,010. The total number of shares, including treasury shares, remains at 6,379,002,274.

The company confirmed that all necessary regulatory and legal requirements for this transaction have been met. This repurchase reflects Jiangsu Hengrui Medicine's ongoing commitment to its employee incentive programs, utilizing market mechanisms to acquire shares for strategic purposes.